The U.S. fertility market is expected to experience steady growth in the coming years due to increasing awareness about fertility treatments, changing lifestyle patterns, and advancements in reproductive technologies. The growing trend of delayed parenthood, rising infertility rates, and the availability of insurance coverage for fertility treatments are also driving the market growth.
Two key growth drivers in the U.S. fertility market include the increasing acceptance of alternative family-building options, such as surrogacy and egg donation, and the rising demand for personalized and precision medicine in fertility treatments. These factors are expected to drive market growth by providing more options to individuals seeking fertility treatments and improving success rates.
On the other hand, two major industry restraints in the U.S. fertility market are the high cost of fertility treatments and the lack of regulation in the industry. The expensive nature of fertility treatments can deter potential patients from seeking help, while the lack of comprehensive regulations can lead to inconsistent quality of care and services across different fertility clinics.
Segment Analysis
The U.S. fertility market can be segmented by procedure type, fertility clinic type, and end-user. In terms of procedure type, the market includes in vitro fertilization (IVF), artificial insemination, surrogacy, and others. Fertility clinics can be categorized as standalone clinics, hospital-based clinics, and others. The end-users of fertility services include couples, single individuals, and the LGBTQ+ community.
Competitive Landscape
The U.S. fertility market is highly competitive, with key players such as Progyny, Inc., Prelude Fertility, Inc., and IntegraMed America, Inc. dominating the market. These companies offer a wide range of fertility services, including IVF, egg freezing, and genetic testing. In order to stay competitive, market players are focusing on expanding their service offerings, investing in research and development, and strategic partnerships with healthcare providers.